Investigation of serum and adipose tissue levels of asprosin in patients with severe obesity undergoing sleeve gastrectomy.
Hasan CantayKenan BinnetogluHuseyin Fatih GulSeyit Ali BingolPublished in: Obesity (Silver Spring, Md.) (2022)
Serum asprosin levels decreased significantly at 6 months after bariatric surgery. Adipose tissue of patients with obesity showed high asprosin levels and immunoreactivity. In conclusion, asprosin levels in adipose tissue were considered a potential independent risk factor in obesity etiopathogenesis.